Lexogen is a biotech company established in 2007. Lexogen’s team of highly qualified molecular biologists, engineers, and bioinformaticians has developed powerful proprietary technologies for transcriptome analyses using next-generation sequencing (NGS).

Lexogen’s products empower researchers to analyze the expression of individual genes as well as the complete transcriptome with unprecedented accuracy.